Dynamics of acute phase indices in patients with rheumatoid arthritis combined with abdominal obesity, type 2 diabetes mellitus and arterial hypertension depending on Т-786С eNOS gene polymorphism following treatment
Journal Title: Міжнародний ендокринологічний журнал - Year 2018, Vol 14, Issue 1
Abstract
Background. The development of modern approaches to the pharmacotherapy of rheumatoid arthritis (RA) associated with abdominal obesity (AO), type 2 diabetes mellitus (DM 2) and arterial hypertension (AH) remains relevant today. The purpose of the study was to investigate the dynamics of acute-phase indices following treatment in patients with RA combined with AO, DM 2 and AH, depending on the T-786C gene polymorphism of endothelial nitric oxide synthase (eNOS). Materials and methods. Sixty patients with RA and 20 apparently healthy persons passed the stage of screening. The polymorphism of the eNOS gene (rs2070744) was determined by polymerase chain reaction, and when evaluating the efficacy of treatment, the presence of comorbid pathology was taken into account. Results. Following treatment, the content of acute phase inflammation indices decreased: C-reactive protein in carriers of unfavorable СС-genotype — by 30.74 % (p = 0.002), TT-genotype — by 44.16 %, and TС-genotype — by 32.21 % (p < 0.001). The level of the rheumatoid factor decreased in the carriers of the TT-genotype by 49.66 % (p < 0.001), TС-genotype — by 26.46 % (p < 0.001) and СС-genotype — by 29.75 % (p < 0.001). The content of cyclic citrullinated peptide antibodies reduced only among carriers of the TT-genotype — by 10.79 % (p < 0.05). The level of antistreptolysin O has probably decreased by 14.07 and 21.44 %, with no statistically significant advantage in СС-genotype carriers (p > 0.05). The content of seromucoid and serum test parameters reduced in СС-genotype carriers by 19.52 (p < 0.05) and 24.56 % (p < 0.05), in carriers of the TT-genotype — by 13.84 (p < 0.05) and 18.71 % (p < 0.05) and TС-genotype — by 18.49 (p < 0.05) and 22.89 % (p < 0.001), respectively. Conclusions. After the treatment, the reduction in the content of the acute phase inflammation indices in the carriers of the TT-genotype was the most significant.
Authors and Affiliations
O. P. Bukach
Keywords
Related Articles
- EP ID EP275650
- DOI 10.22141/2224-0721.14.1.2018.127086
- Views 55
- Downloads 0
Motivation sphere features of patients with psychoendocrine syndrome on the background of hypogonadism
Background. Psychoneuroendocrinology is the clinical study of hormone fluctuations and their relationship to human behavior. It may be viewed from the perspective of psychiatry, where in certain mood disorders, there are...
Indicators of endothelial dysfunction in type 2 diabetes mellitus as factors for the development of complications
Background. To determine the pathogenetic role of the main factors reflecting the development of endothelial dysfunction (EDF), an attempt was made within the framework of one study to calculate their effect on the occur...
Pleiotropic Effects of Metformin: Antioncogenic Action (Literature Review)
Diabetes mellitus (DM) is associated with increased risk of cancers of some localizations and a moderate increase in cancer death. Leading pathogenetic role in the relationship of DM and malignant disease belongs to chro...
Influence of Endocrine Diseases on Reproductive System Functioning
In the lecture the questions of endocrine diseases influence on the reproductive system functioning are being considered. The reproductive system of woman is analyzed as a complex of interdependent structural elements: h...
The Use of Sugar Substitutes and Sweeteners in Diet Therapy of Diabetes and Obesity
The article provides a description of the main sugar substitutes and sweeteners that do not have negative impact on glycaemic parameters and can be used by patients with with diabetes mellitus and obesity without the fea...